CH, Cameron JC. Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations. Ann Pharmacother. 2012;46(4):549–57. https://pubmed.ncbi.nlm.nih.gov/22474137/

5057

Sabbagh MN, Perez A, Holland TM, et al. Primary prevention recommendations to reduce the risk of cognitive decline. Alzheimers Dement. Published online January 13, 2022.; https://pubmed.ncbi.nlm.nih.gov/35026040/

5058

Barnard ND, Bush AI, Ceccarelli A, et al. Dietary and lifestyle guidelines for the prevention of Alzheimer’s disease. Neurobiol Aging. 2014;35 Suppl 2:S74–8. https://pubmed.ncbi.nlm.nih.gov/24913896/

5059

Wood WG, Li L, Müller WE, Eckert GP. Cholesterol as a causative factor in Alzheimer disease: a debatable hypothesis. J Neurochem. 2014;129(4):559–72. https://pubmed.ncbi.nlm.nih.gov/24329875/

5060

Testa G, Staurenghi E, Zerbinati C, et al. Changes in brain oxysterols at different stages of Alzheimer’s disease: their involvement in neuroinflammation. Redox Biol. 2016;10:24–33. https://pubmed.ncbi.nlm.nih.gov/27687218/

5061

Marwarha G, Ghribi O. Does the oxysterol 27-hydroxycholesterol underlie Alzheimer’s disease – Parkinson’s disease overlap? Exp Gerontol. 2015;68:13–8. https://pubmed.ncbi.nlm.nih.gov/25261765/

5062

Wang HL, Wang YY, Liu XG, et al. Cholesterol, 24-hydroxycholesterol, and 27-hydroxycholesterol as surrogate biomarkers in cerebrospinal fluid in mild cognitive impairment and Alzheimer’s disease: a meta-analysis. J Alzheimers Dis. 2016;51(1):45–55. https://pubmed.ncbi.nlm.nih.gov/26836015/

5063

Gamba P, Testa G, Gargiulo S, Staurenghi E, Poli G, Leonarduzzi G. Oxidized cholesterol as the driving force behind the development of Alzheimer’s disease. Front Aging Neurosci. 2015;7:119. https://pubmed.ncbi.nlm.nih.gov/26150787/

5064

Deschaintre Y, Richard F, Leys D, Pasquier F. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology. 2009;73(9):674–80. https://pubmed.ncbi.nlm.nih.gov/19720973/

5065

Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16. https://pubmed.ncbi.nlm.nih.gov/26551272/

5066

Williamson JD, Pajewski NM, Auchus AP, et al. Effect of intensive vs standard blood pressure control on probable dementia. JAMA. 2019;321(6):553–61. https://pubmed.ncbi.nlm.nih.gov/30688979/

5067

Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16. https://pubmed.ncbi.nlm.nih.gov/26551272/

5068

Roher AE, Tyas SL, Maarouf CL, et al. Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia. Alzheimers Dement. 2011;7(4):436–44. https://pubmed.ncbi.nlm.nih.gov/21388893/

5069

Pase MP, Herbert A, Grima NA, Pipingas A, O’Rourke MF. Arterial stiffness as a cause of cognitive decline and dementia: a systematic review and meta-analysis. Intern Med J. 2012;42(7):808–15. https://pubmed.ncbi.nlm.nih.gov/22151013/

5070

Henskens LHG, van Oostenbrugge RJ, Kroon AA, de Leeuw PW, Lodder J. Brain microbleeds are associated with ambulatory blood pressure levels in a hypertensive population. Hypertension. 2008;51(1):62–8. https://pubmed.ncbi.nlm.nih.gov/18071062/

5071

Kovacic JC, Fuster V. Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease. Mt Sinai J Med. 2012;79(6):664–73. https://pubmed.ncbi.nlm.nih.gov/23239205/

5072

Longstreth WT, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol. 1998;55(9):1217–25. https://pubmed.ncbi.nlm.nih.gov/9740116/

5073

Vermeer SE, Longstreth WT, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6(7):611–9. https://pubmed.ncbi.nlm.nih.gov/17582361/

5074

Beauchet O, Celle S, Roche F, et al. Blood pressure levels and brain volume reduction: a systematic review and meta-analysis [published correction appears in J Hypertens. 2013;31(10):2106]. J Hypertens. 2013;31(8):1502–16. https://pubmed.ncbi.nlm.nih.gov/23811995/

5075

Peila R, White LR, Petrovich H, et al. Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia Aging Study. Stroke. 2001;32(12):2882–9. https://pubmed.ncbi.nlm.nih.gov/11739991/

5076

Singer J, Trollor JN, Baune BT, Sachdev PS, Smith E. Arterial stiffness, the brain and cognition: a systematic review. Ageing Res Rev. 2014;15:16–27. https://pubmed.ncbi.nlm.nih.gov/24548924/

5077

Salvi P, Giannattasio C, Parati G. High sodium intake and arterial stiffness. J Hypertens. 2018;36(4):754–8. https://pubmed.ncbi.nlm.nih.gov/29489612/

5078

D’Elia L, Galletti F, La Fata E, Sabino P, Strazzullo P. Effect of dietary sodium restriction on arterial stiffness: systematic review and meta-analysis of the randomized controlled trials. J Hypertens. 2018;36(4):734–43. https://pubmed.ncbi.nlm.nih.gov/29084085/

5079

Filippini T, Malavolti M, Whelton PK, Naska A, Orsini N, Vinceti M. Blood pressure effects of sodium reduction: dose-response meta-analysis of experimental studies. Circulation. 2021;143(16):1542–67. https://pubmed.ncbi.nlm.nih.gov/33586450/

5080

Siriopol D, Covic A, Iliescu R, et al. Arterial stiffness mediates the effect of salt intake on systolic blood pressure. J Clin Hypertens (Greenwich). 2018;20(11):1587–94. https://pubmed.ncbi.nlm.nih.gov/30295011/

5081

Santisteban MM, Iadecola C. Hypertension, dietary salt and cognitive impairment. J Cereb Blood Flow Metab. 2018;38(12):2112–28. https://pubmed.ncbi.nlm.nih.gov/30295560/

5082

Faraco G, Hochrainer K, Segarra SG, et al. Dietary salt promotes cognitive impairment through tau phosphorylation. Nature. 2019;574(7780):686–90. https://pubmed.ncbi.nlm.nih.gov/31645758/

5083

Fyfe I. High-salt diet promotes Alzheimer disease – like changes. Nat Rev Neurol. 2020;16(1):2–3. https://pubmed.ncbi.nlm.nih.gov/31712717/

5084

Cahill S, Pierce M, Werner P, Darley A, Bobersky A. A systematic review of the public’s knowledge and understanding of Alzheimer’s disease and dementia. Alzheimer Dis Assoc Disord. 2015;29(3):255–75. https://pubmed.ncbi.nlm.nih.gov/26207322/

5085

Hudson JM, Pollux PMJ, Mistry B, Hobson S. Beliefs about Alzheimer’s disease in Britain. Aging Ment Health. 2012;16(7):828–35. https://pubmed.ncbi.nlm.nih.gov/22416945/

5086

Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 2006;5(9):735–41. https://pubmed.ncbi.nlm.nih.gov/16914401/

5087

Chandra V, Ganguli M, Pandav R, et al. Prevalence of Alzheimer’s disease and other dementias in rural India: the Indo-US study. Neurology. 1998;51(4):1000–8. https://pubmed.ncbi.nlm.nih.gov/9781520/

5088

Shetty